From October 1, 2022 to December 15, 2022, the company has repurchased 394,400 shares, representing 0.11% for CNY 9.28 million. With this, the company has completed the repurchase of 2,403,643 shares, representing 0.69% for CNY 58 million under the buyback announced on June 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.79 CNY | +0.92% | -0.29% | -4.24% |
05-06 | China Approves Tianyu Pharma's Heart Medication | MT |
04-26 | Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Profit Distribution Proposal for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.24% | 988M | |
+17.38% | 22.02B | |
+18.55% | 15.08B | |
+18.91% | 14.37B | |
+58.31% | 13.06B | |
-9.80% | 6.75B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.66% | 5.64B | |
+4.00% | 4.66B |
- Stock Market
- Equities
- 300702 Stock
- News Zhejiang Tianyu Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 30, 2022.